Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil in Strabismus Correction
NCT07112157Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of oliceridine in strabismus (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: Adequate rate of intraoperative analgesia at 1 day and Success rate of initial insertion of laryngeal mask at 1 day. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT07112157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112157.